Tramadol safety concerns arise from its serotonergic activity; which risk is most associated?

• A. Serotonin syndrome risk with other serotonergic meds.
• B. Seizure risk.
• C. Nephrotoxicity.
• D. Severe hypertension.

Answer: (B)

Tramadol’s serotonergic action increases synaptic serotonin by inhibiting its reuptake, on top of its opioid effects. Elevating serotonin levels can heighten brain excitability and lower the seizure threshold, especially at higher doses or when combined with other drugs that also raise serotonin or lower seizure threshold. This makes seizure risk the most directly linked safety concern to its serotonergic activity. Serotonin syndrome can occur with concomitant serotonergic meds, but seizures are the more characteristic and prominent risk tied to tramadol’s serotonergic effect. Nephrotoxicity and severe hypertension are not central risks from this mechanism.